SEC Form 13F Information Table Summary
Business Context and Reporting Period
Company: Carlyle Group Inc.
Filing Type: Form 13F Information Table (Schedule of Investments)
Reporting Period: The filing text references a period date of June 30, 2026, in the metadata, though the document content itself does not explicitly state the quarter end date within the visible table rows. Form 13F filings are required quarterly for institutional investment managers with over $100 million in qualifying assets.
Key Financial Metrics and Portfolio Holdings
This filing details specific equity holdings rather than the company's own financial performance (revenue, profit, or cash flow). The table lists 19 distinct issuers with their share counts and total market values.
| Issuer | Shares Held | Value (USD) | Voting Authority |
|---|---|---|---|
| Medline Inc | 187,083,713 | $7,378,581,641 | Sole |
| Standardaero Inc | 84,587,035 | $2,529,998,217 | Sole |
| Phathom Pharmaceuticals Inc | 3,496,808 | $37,940,367 | Sole |
| Pony Ai Inc | 2,362,447 | $16,419,007 | Shared |
| SunPower Inc | 2,343,750 | $1,610,859 | Shared |
| Getty Images Holdings Inc | 6,234,252 | $5,361,457 | Sole |
| Jasper Therapeutics Inc | 1,066,189 | $448,866 | Sole |
| Adicet Bio Inc | 184,295 | $1,592,308 | Sole |
| Forward Air Corp | 107,214 | $1,448,461 | Sole |
| Krispy Kreme Inc | 340,748 | $1,202,840 | Sole |
| Onkure Therapeutics Inc | 269,895 | $1,230,721 | Sole |
| Invitation Homes Inc | 662,900 | $20,026,209 | Sole |
| N-able Inc | 93,732 | $343,996 | Sole |
| Nebius Group N.V. | 1,846 | $509,810 | Sole |
| Q32 Bio Inc | 60,363 | $769,020 | Sole |
| Ramaco Res Inc | 21,743 | $287,667 | Sole |
| Riley Exploration Permian In | 16,092 | $530,387 | Sole |
| Robinhood Mkts Inc | 4,733 | $474,625 | Sole |
| Spruce Biosciences Inc | 38,620 | $2,085,493 | Sole |
Note: The "Value" column in the source text appears to be misaligned with standard 13F formatting in some rows (e.g., Medline and Standardaero values are exceptionally high relative to share counts, suggesting potential data parsing anomalies in the source text or specific class structures). The summary reflects the numbers exactly as presented in the input.
Material Changes and Guidance
Material Changes: The filing text does not provide comparative data from the prior quarter; therefore, material changes in holdings cannot be determined from this document alone.
Guidance and Outlook: Form 13F filings are historical disclosures of holdings and do not contain management commentary, forward-looking guidance, or risk factors regarding the reporting company's own operations.
Unusual Items: The filing includes holdings in "Sponsored Ads" (Pony Ai Inc) and "Com New" (Adicet Bio Inc, Jasper Therapeutics Inc, Spruce Biosciences Inc), indicating recent IPOs or special classes of stock.
Key Facts for Investor Verification
- Concentration Risk: The portfolio is heavily concentrated in two positions: Medline Inc and Standardaero Inc, which represent the vast majority of the reported value in this specific table.
- Data Integrity: Investors should verify the "Value" column for Medline Inc ($7.3B) and Standardaero Inc ($2.5B) against current market prices, as the share counts and values appear disproportionately high compared to typical market capitalizations for these entities, suggesting a potential data entry error in the source text.
- Voting Rights: Most positions are held with "Sole" voting authority, but Pony Ai Inc and SunPower Inc are listed with "Shared" voting authority.
- Reporting Date: Confirm the actual quarter-end date with the SEC EDGAR database, as the metadata date (June 30, 2026) is in the future relative to the current real-time date, which may indicate a projection or a data error in the metadata provided.